Caricamento...
Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment
The nonvitamin K antagonist oral anticoagulants (NOACs), also referred to as direct oral anticoagulants (DOACs), dabigatran, apixaban, edoxaban, and rivaroxaban, have emerged as effective alternatives to vitamin K antagonists (VKAs) across several indications, including the prevention of stroke and...
Salvato in:
| Pubblicato in: | Ther Adv Cardiovasc Dis |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5562140/ https://ncbi.nlm.nih.gov/pubmed/28651452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944717714921 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|